An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?

Mohit Khera, Trinity Bivalacqua, Irwin Goldstein, Maarten Albersen

Research output: Contribution to journalComment/debate

Abstract

Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.

Original languageEnglish (US)
JournalEuropean Urology Focus
DOIs
StatePublished - Jan 1 2019

Fingerprint

Regenerative Medicine
Erectile Dysfunction
Cell- and Tissue-Based Therapy
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction : Have We Made Any Progress? / Khera, Mohit; Bivalacqua, Trinity; Goldstein, Irwin; Albersen, Maarten.

In: European Urology Focus, 01.01.2019.

Research output: Contribution to journalComment/debate

@article{91464709cd2f410997102a5fc1b782dd,
title = "An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?",
abstract = "Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.",
author = "Mohit Khera and Trinity Bivalacqua and Irwin Goldstein and Maarten Albersen",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.euf.2019.05.017",
language = "English (US)",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction

T2 - Have We Made Any Progress?

AU - Khera, Mohit

AU - Bivalacqua, Trinity

AU - Goldstein, Irwin

AU - Albersen, Maarten

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.

AB - Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.

UR - http://www.scopus.com/inward/record.url?scp=85066785896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066785896&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2019.05.017

DO - 10.1016/j.euf.2019.05.017

M3 - Comment/debate

C2 - 31196678

AN - SCOPUS:85066785896

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

ER -